Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to -$1.6 million.

  • Enanta Pharmaceuticals' Other Working Capital Changes fell 15505.51% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 2098.52%. This contributed to the annual value of $379000.0 for FY2025, which is 9241.09% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Other Working Capital Changes of -$1.6 million as of Q3 2025, which was down 15505.51% from $314000.0 recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Other Working Capital Changes ranged from a high of $4.5 million in Q4 2022 and a low of -$9.8 million during Q2 2021
  • Its 5-year average for Other Working Capital Changes is -$760736.8, with a median of -$737000.0 in 2022.
  • Within the past 5 years, the most significant YoY rise in Enanta Pharmaceuticals' Other Working Capital Changes was 45101.76% (2023), while the steepest drop was 198152.17% (2023).
  • Enanta Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$2.7 million in 2021, then soared by 267.82% to $4.5 million in 2022, then tumbled by 122.73% to -$1.0 million in 2023, then crashed by 69.01% to -$1.7 million in 2024, then rose by 4.57% to -$1.6 million in 2025.
  • Its Other Working Capital Changes was -$1.6 million in Q3 2025, compared to $314000.0 in Q2 2025 and $265000.0 in Q1 2025.